Literature DB >> 14501644

Lower urinary tract reconstruction is safe and effective in children with end stage renal disease.

William DeFoor1, Eugene Minevich, Paul McEnery, Leslie Tackett, Deborah Reeves, Curtis Sheldon.   

Abstract

PURPOSE: Congenital urinary tract anomalies with bladder dysfunction pose a formidable management challenge in children with end stage renal disease (ESRD). We report a series of patients with ESRD who underwent lower urinary tract reconstruction to assess the results and surgical complications.
MATERIALS AND METHODS: We retrospectively reviewed the medical records of patients with ESRD who underwent urinary reconstruction. The etiology for renal failure included posterior urethral valves, cloacal anomalies, VATER syndrome and reflux nephropathy.
RESULTS: From 1989 to 2000, 20 patients were identified. Median patient age at time of reconstruction was 4.5 years and median followup was 7.3 years. Pre-transplant augmentation cystoplasty was performed in 14 patients (70%) and continent reconstruction without bladder augmentation was performed in 6 patients. Subsequent renal transplant was performed in 19 patients (15 with a living related donor). Overall patient survival was 95%. There was 1 death in the immediate post-transplant period secondary to cerebral edema thought to be due to a precipitous decrease in blood urea nitrogen. The overall graft survival rate is 82%. No patients lost grafts due to infection or technical complications. All patients have stable upper tracts, and mean creatinine is 1.2 mg/dl. Three patients required major surgery due to complications of the reconstruction and 2 treated with gastrocystoplasty had severe hematuria while anuric before transplantation. All patients are continent of urine.
CONCLUSIONS: Our long-term data confirm that severe bladder dysfunction can be managed safely and effectively with continent urinary reconstruction in children with ESRD.

Entities:  

Mesh:

Year:  2003        PMID: 14501644     DOI: 10.1097/01.ju.0000084386.63639.25

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Midterm outcomes of protection for upper urinary tract function by augmentation enterocystoplasty in patients with neurogenic bladder.

Authors:  Limin Liao; Fan Zhang; Guoqing Chen
Journal:  Int Urol Nephrol       Date:  2014-07-23       Impact factor: 2.370

Review 2.  Kidney transplants in patients with bladder augmentation: correlation and evolution.

Authors:  Jose Maria Garat; Jorge Caffaratti; Oriol Angerri; Anna Bujons; Humberto Villavicencio
Journal:  Int Urol Nephrol       Date:  2007-01-09       Impact factor: 2.370

3.  Renal transplantation in children weighing <15 kg: does concomitant lower urinary tract dysfunction influence the outcome?

Authors:  Giulia Ghirardo; Paola Midrio; Pietro Zucchetta; PierGiorgio Gamba; GiovanniFranco Zanon; Luisa Murer; Marco Castagnetti
Journal:  Pediatr Nephrol       Date:  2015-01-20       Impact factor: 3.714

4.  Chronic kidney disease in the VACTERL association: clinical course and outcome.

Authors:  Sun-Young Ahn; Stanley Mendoza; George Kaplan; Vivian Reznik
Journal:  Pediatr Nephrol       Date:  2009-01-27       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.